該公司於二零二五年十月十七日之股權架構如下： 公布 二零二五年十一月四日 股權高度集中 Home Control International Limited (股份代號：1747) 證券及期貨事務監察委員會("證監會")現就 Home Control International Limited("該公司")之 股權於二零二五年十月十七日集中於極少數股東一事發出此公布。 鑑於股權高度集中於數目不多之股東，即使少量股份成交，該公司之股份價格亦可能大幅波 動，股東及有意投資者於買賣該公司股份時務請審慎行事。 證監會最近曾就該公司之股權分佈進行查訊。查訊結果顯示該公司於二零二五年十月十七日， 有二十名股東合共持有88,908,000 股該公司股份，相當於該公司已發行股本之17.55%。有關股 權連同由一名該公司的主要股東持有之375,202,000股 (佔已發行股本之74.06%)，相當於該公司 已發行股本之91.61%。因此，該公司只有42,540,000股（佔已發行股本之8.39%）由其他股東持 有。 完 2 | | | 佔已發行股份 | | --- | --- | --- | | | 所持股份數目 | 總額百分 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: Home Control International Limited (於開曼群島註冊成立的有限公司) 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01747 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | USD | | 0.01 USD | | 50,000,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 5,000,000,000 | USD | | 0.01 USD ...

Group 1 - The company has established a wholly-owned subsidiary in Hong Kong named Orbiva Limited, with the registration completed on September 22, 2025 [1] - The decision to create Orbiva Limited is driven by the increasing global demand for healthcare and the company's achievements in the healthcare sector, leveraging its expertise in IoT and smart control technologies [1] - Orbiva Limited will serve as a new strategic core for the company, focusing on expanding its healthcare-related business, including an AIoT-enabled home healthcare platform and ecosystem [1] Group 2 - The company will maintain its existing product-based healthcare business while allowing Orbiva Limited to operate independently under the original structure [1] - The new brand under Orbiva Limited will aim to integrate hardware, software, data, and services to provide comprehensive healthcare operational services [1]

Core Insights - HOME CONTROL (01747) has established a wholly-owned subsidiary named Orbiva Limited in Hong Kong to expand its healthcare business in response to growing global healthcare demands [1][2] - Orbiva Limited will focus on developing an AIoT-enabled home healthcare platform and ecosystem, integrating hardware, software, data, and services [1] Company Developments - The formation of Orbiva Limited was completed on September 22, 2025, under Hong Kong's Companies Ordinance [1] - The company aims to leverage its existing IoT and smart control technologies along with the expertise of its new board members to drive its healthcare initiatives [1] Strategic Partnerships - Orbiva Limited is exploring collaborations with renowned academic institutions for joint laboratories and other suitable forms of cooperation in technology research and development [2] - The company is in discussions with leading hardware suppliers to define and develop products, as well as engaging with fintech institutions for innovative business models [2] - The board anticipates progress in these collaborations and will continue to seek partnership opportunities in the outlined business directions [2]

Core Viewpoint - The company has established a wholly-owned subsidiary, Orbiva Limited, in Hong Kong to expand its healthcare business, leveraging its expertise in IoT and smart control technologies [1][2] Group 1: Company Establishment - Orbiva Limited was officially registered on September 22, 2025, under Hong Kong's Companies Ordinance and other applicable laws [1] - The new subsidiary will serve as a strategic core for the company, focusing on broader healthcare-related business opportunities [1] Group 2: Business Strategy - The company aims to maintain its existing product-based healthcare operations while independently operating Orbiva Limited [1] - Orbiva Limited will focus on developing an AIoT-enabled home healthcare platform and ecosystem, integrating hardware, software, data, and services [1] Group 3: Future Development - The board is optimistic about Orbiva Limited's future, exploring collaborations with renowned academic institutions for joint laboratories [2] - The company is in discussions with leading hardware suppliers for product definition and development [2] - Initial communications are underway with fintech institutions to explore innovative business models [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 HOME CONTROL INTERNATIONAL LIMITED （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：1747） 自願性公告 業務發展更新 本公告由Home Control International Limited（「本公司」，連 同 其 附 屬 公 司 統 稱「本 集 團」）自 願 刊 發，旨 在 向 本 公 司 股 東（「股 東」）及潛在投資者提供有關本集團戰略 佈 局 及 規 劃 的 最 新 資 料。 茲 提 述 本 公 司 日 期 為 二 零 二 五 年 九 月 十 二 日 之 自 願 性 公 告，內 容 有 關 註 冊 成 立一家全資附屬公司（「該公告」）。除 另 有 界 定 者 外，本 公 告 所 用 詞 彙 與 該 公 告 所 界 定 者 具 有 相 同 涵 義。 董 事 會 欣 然 宣 ...

Core Viewpoint - The company is initiating a strategic expansion into the healthcare sector, launching a new brand and establishing a wholly-owned subsidiary in Hong Kong to capitalize on market opportunities [1] Company Strategy - The board has approved a business expansion plan and brand revamp, focusing on healthcare as a key area for growth [1] - The establishment of the Hong Kong subsidiary aims to explore the development of a health monitoring and management ecosystem [1] Market Position - The company plans to leverage its existing home-based business foundation and collaborate with experts to gradually develop its health business landscape [1] - In the first half of 2025, the healthcare solutions segment is expected to contribute approximately 19.7% to the company's overall revenue [1] Future Outlook - The company is optimistic about the global health industry and aims to seize opportunities for strategic positioning in the healthcare sector [1]

Group 1 - The company, HOME CONTRO (01747), announced a strategic expansion into the healthcare sector, launching a new brand and establishing a wholly-owned subsidiary in Hong Kong [1] - The board believes that these strategic initiatives will allow the company to explore opportunities in health monitoring and management ecosystems, leveraging its existing home-based business [1] - In the first half of 2025, the healthcare solutions segment accounted for approximately 19.7% of the company's overall revenue, indicating initial success in this new venture [1] Group 2 - The company aims to collaborate with relevant institutions and experts to gradually develop and enhance its health business landscape [1] - The global health industry presents a favorable outlook, and the company plans to seize opportunities for strategic development in the healthcare sector [1]

Core Viewpoint - HOME CONTROL (01747.HK) is initiating a strategic expansion into the healthcare sector, establishing a wholly-owned subsidiary in Hong Kong and launching a new brand series of products and services [1] Group 1: Business Expansion - The company has decided to implement a business expansion plan and brand revitalization as of September 12, 2025 [1] - A wholly-owned subsidiary has been established in Hong Kong to kickstart its strategic layout in the healthcare sector [1] Group 2: Market Opportunities - The strategic initiatives aim to leverage family health as an entry point to explore opportunities in building a health monitoring and management ecosystem [1] - The company plans to develop its health business by collaborating with relevant institutions and experts, utilizing its existing home-based business foundation [1] Group 3: Financial Performance - In the first half of 2025, the healthcare solutions segment is expected to contribute approximately 19.7% to the company's overall revenue [1] - The company is optimistic about the future prospects of the global health industry and aims to seize opportunities for strategic development in the healthcare sector [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 註冊成立一家全資附屬公司 本公告由Home Control International Limited（「本公司」，連 同 其 附 屬 公 司 統 稱「本 集 團」）自 願 刊 發，旨 在 就 本 集 團 業 務 拓 展 及 品 牌 形 象 升 級 事 項 向 本 公 司 股 東（「股 東」）及 潛 在 投 資 者 提 供 最 新 資 料。於 二 零 二 五 年 九 月 十 二 日，本 公 司 董 事（「董 事」）會（「董事會」）議 決 推 行 其 業 務 擴 展 方 案 及 相 應 的 品 牌 重 塑 工 作。就 前 文 所 述，董 事 會 欣 然 宣 佈，本 集 團 已 啟 動 其 在 醫 療 保 健 領 域 的 戰 略 性 佈 局 以 把 握 市 場 機 遇，且 作 為 起 步，已 在 香 港 成 立 一 家 全 資 附 屬 公 司（「香港附 ...